1) WHO, New vaccines against cervical cancer major opportunity for developing world, Press December, 2006
2) Wallin KL, Wiklund F, Angstrom T, et al:Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med 341:1633-1638, 1999
3) Herrero R, Hidesheim A, Bratti C, et al:A population-based study of human papillomavirus infection and all grades of cervical neoplasia in rural Costa Rica. J Nat Cancer Inst 14:464-474, 2000
4) Walboomers JM, Jacobs MV, Manos MM, et al:Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol Sep 189:12-19, 1999
5) Meisels A, Begin R, Schneider V:Condylomatous lesion of the cervix, colposcopic and histopathologic study. Acta Cytol 21:379-390, 1977
6) Meisels A, Roy M, Fortier M, et al:Human papillomavirus infection of the cervix:the atypical condyloma. Acta Cytol 25:7-16, 1981
7) 吉田則行,寺島英雄,平田守男,他:ヒトパピローマウィルス(HPV)感染細胞所見の検討―細胞診によるHPV感染推定のために.日本臨床細胞学会雑誌 29:493-499,1990
8) Ishi K, Suzuki F, Saito A, et al:Prevalence of human papillomavirus infection and correlation with cervical lesions in Japanese woman. J Obset Gynecol Res 30:380-385, 2004
9) National Cancer Institute Workshop:The Bethesda system for reporting cervical/vaginal cytological diagnosis. JAMA 262:931-934, 1989
10) Solomon D, Davey D, Kurman R, et al:The 2001 Bethesda System:terminology for reporting results of cervical cytology. JAMA 287:2114-2119, 2002
11) 岩坂剛,内山倫子:新しい子宮頸癌スクリーニング法:HPV testing.細胞 13:517-521,2006
12) Wright TC Jr, Schiffman M, Solomon D, et al:Interim guidance for the use of human papillomavirus DNA Testing as an adjunct to cervical cytology for screening. Obstet Gynecol 103:304-309, 2004